| 000 | 01610 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518070438.0 | ||
| 264 | 0 | _c20200810 | |
| 008 | 202008s 0 0 eng d | ||
| 022 | _a1865-3774 | ||
| 024 | 7 |
_a10.1007/s12185-019-02771-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHiramatsu, Hidefumi | |
| 245 | 0 | 0 |
_aEfficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia. _h[electronic resource] |
| 260 |
_bInternational journal of hematology _cFeb 2020 |
||
| 300 |
_a303-310 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAsian People |
| 650 | 0 | 4 | _aB-Lymphocytes |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xtherapeutic use |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aAdachi, Souichi | |
| 700 | 1 | _aUmeda, Katsutsugu | |
| 700 | 1 | _aKato, Itaru | |
| 700 | 1 | _aEldjerou, Lamis | |
| 700 | 1 | _aAgostinho, Andrea Chassot | |
| 700 | 1 | _aNatsume, Kazuto | |
| 700 | 1 | _aTokushige, Kota | |
| 700 | 1 | _aWatanabe, Yoko | |
| 700 | 1 | _aGrupp, Stephan A | |
| 773 | 0 |
_tInternational journal of hematology _gvol. 111 _gno. 2 _gp. 303-310 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12185-019-02771-2 _zAvailable from publisher's website |
| 999 |
_c30295701 _d30295701 |
||